About deepu

This author has not yet filled in any details.
So far deepu has created 13 blog entries.

DeepPath™-LYDIA in Sectra Digital Pathology Solution

By |2022-12-21T10:21:14+02:00December 20th, 2022|Categories: News|Tags: , |

We are happy to announce that we completed our integration of DeepPathTM-LYDIA in the Sectra Digital Pathology solution. We are particularly excited as DeepPathTM-LYDIA is the first lymph-node metastasis detection solution to be officially featured in Sectra Amplifier Marketplace for Digital Pathology. About DeepPathTM-LYDIA DeepPathTM-LYDIA is DeepMed’s CE-Marked AI-powered decision support system for metastasis detection on [...]

First Award in NBG Seeds Competition

By |2022-06-21T00:05:11+03:00June 20th, 2022|Categories: Uncategorized|Tags: |

It has been a privilege for the company to participate in the 12th National Bank of Greece Seeds competition and a great honor to receive the first award for our metastasis detection system that provides decision support on the staging of breastcancer, coloncancer, lungcancer as well as melanoma patients. The system is called DeepPath™-LYDIA, received cemarking [...]

CE Mark for DeepPath™ – LYDIA

By |2022-06-06T15:06:14+03:00June 6th, 2022|Categories: Uncategorized|Tags: , |

We are super excited to announce that DeepMedIO receives CE marking for DeepPath™ - LYDIA. The system got regulatory clearance as decision support as per IVDD for helping histopathologists detect metastases on Hematoxylin & Eosin stained lymph nodes from patients with breast cancer, colon cancer, lung cancer, and melanoma. We must note that to the best [...]

€4m Pathfinder Grant

By |2022-06-06T15:28:43+03:00May 6th, 2022|Categories: Uncategorized|Tags: , , |

We are happy to announce that DeepMed IO as part of a consortium consisting of MIDA Biotech B.V. (an Orgenesis Inc. company), Leiden University, and MIRCOD LLC, acquired a €4m Pathfinder grant from European Innovation Council and SMEs Executive Agency (EISMEA) for the development of an Ai-powered platform to democratize autologous IPCS manufacturing! This is a [...]

DeepMed IO part of Greek MNEC delegation in the United Arab Emirates

By |2022-06-06T13:15:10+03:00February 2nd, 2022|Categories: Uncategorized|Tags: , |

DeepMed IO was part of the Hellenic Ministry of Development and Investments delegation in the United Arab Emirates led by the Deputy Minister Dr. Christos Dimas. We presented our company at the Expo 2020 Dubai, and had multiple meetings with individuals from the academic community as well as from major accelerators and Investement funds like Dubai [...]

DeepMedIO in TIF2021

By |2022-06-06T14:38:46+03:00October 6th, 2021|Categories: Uncategorized|Tags: , |

DeepMed IO through its Greek-Branch participated in Thessaloniki International Fair supported by Elevate Greece and ΓΓΕΚ. We were given the chance to present DeepPath(TM)-LYDIA, our close-to-market ΑΙ-powered decision support system for βreastcancer staging, and got to interact with the greek startup medtech ecosystem. What a great experience!

EN ISO13485:2016 certification granted

By |2022-06-02T16:16:15+03:00July 10th, 2020|Categories: News|Tags: , |

Manchester, UK – DeepMed IO Ltd announced today that its quality management system (QMS) has been successfully certified as per ISO 13485:2016 requirements by HTCert Notified Body (2803) with scope “Design, development, production, technical assistance and installation of medical device software for precision medicine and digital/computational pathology”. DeepMed IO Ltd ISO 13485:2016 certification serves to [...]

Deepmed IO and Inspirata Partnership

By |2022-06-20T23:44:21+03:00May 14th, 2020|Categories: News|Tags: |

We are excited to announce our new technical partnership with Inspirata! DeepPath™ LYDIA, DeepMed IO's AI-powered Metastasis Detection Technology can now be integrated into Inspirata's Dynamyx™ through its open API. Dynamyx™ streamlines case management, facilitates communication and accelerates pathology workflows, while DeepPath™ LYDIA uses AI to offer decision support for faster and more accurate staging as [...]

We are extremely exited because on November 27, 2019 our team made its 3rd submission to the #camelyon17 Grand Challenge achieving a k of 90.52%!

By |2022-06-02T16:16:15+03:00November 27th, 2019|Categories: News|

We are extremely exited because on November 27, 2019 our team made its 3rd submission to the #camelyon17 Grand Challenge achieving a k of 90.52%! This makes our solution the 5th best submitted one in the world among 62 teams and 98 submissions. It must be mentioned that there are only 3 companies present including DeepMed [...] One of many AI start-ups benefitting from Nvidia’s Inception Program

By |2022-06-02T16:16:15+03:00November 26th, 2019|Categories: News|

As part of the Nvidia Inception Program, the UK start-up has used AI to help pathologists classify and detect breast cancer in tissue samples Artificial intelligence and machine learning are being used increasingly in the healthcare industry to make life easier for doctors and improve patient outcomes (Credit: Pixabay) One of the biggest challenges for any [...]

Go to Top